WASHINGTON — Next year’s Congress will be divided. But when it comes to efforts to lower drug prices, suddenly everyone is on the same page.
First came the surprising remarks from Senate Majority Leader Mitch McConnell, who has until now said little about his interest in the high price of medicines.
“Yeah, I can’t imagine that that won’t be on the agenda,” the Kentucky Republican said at a news conference Wednesday.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.